https://www.marketscreener.com/quote/stock/SYNDAX-PHARMACEUTICALS-IN-16725742/news/Syndax-Pharmaceuticals-Announces-Results-from-the-Pivotal-AGAVE-201-Trial-of-Axatilimab-in-Chronic-G-45225744/?utm_source=telegram&utm_medium=social&utm_campaign=share